ABMD will go back to $20+
Good earning, good outlook. This stock will go back to above $20.
Don't be tricked by the short sellers.
"Abiomed Announces Revenue of $37.4 Million, Up 27% and Worldwide Impella(R) Revenue Growth of 32%"
Sentiment: Strong Buy